Andrew Whelton
Impact in
- Pharmacology top 0.05%
- Inflammatory mediators and NSAID effects
- Drug-Induced Adverse Reactions
- Pharmacogenetics and Drug Metabolism
- Nephrology top 0.5%
- Gout, Hyperuricemia, Uric Acid
Papers in
- Pharmacology 67
- Inflammatory mediators and NSAID effects 39
- Antibiotics Pharmacokinetics and Efficacy 25
- Pharmacogenetics and Drug Metabolism 12
- Nephrology 22
- Gout, Hyperuricemia, Uric Acid 14
- Co-authors
- Kenneth M. VerburgGilbert GeisJ B LefkowithWilliam B. WhiteGerald A. FaichJeffrey D. KentLee S. SimonFred E. Silverstein
- Journals
- American Journal of Therapeutics (19 papers)The Journal of Clinical Pharmacology (18 papers)The American Journal of Medicine (5 papers)Journal of the American College of Cardiology (5 papers)The American Journal of Cardiology (5 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Andrew Whelton
141 papers receiving 7.8k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Pharmacology 4.8k
- Nephrology 1.3k
- Biochemistry 1.1k
- Pharmacology 959
- Cardiology and Cardiovascular Medicine 1.9k
Countries citing papers authored by Andrew Whelton
This map shows the geographic impact of Andrew Whelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Whelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Whelton more than expected).
Fields of papers citing papers by Andrew Whelton
This network shows the impact of papers produced by Andrew Whelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Whelton. The network helps show where Andrew Whelton may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Whelton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout Hit paper breakdown → | 2018 | 578 |
| 3 | 2007 | 17 | |
| 4 | 2006 | 116 | |
| 5 | Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery Hit paper breakdown → | 2005 | 808 |
| 6 | 2004 | 56 | |
| 7 | 2003 | 3 | |
| 8 | Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors. | 2002 | 13 |
| 9 | Cyclooxygenase-2 inhibition and renal function (multiple letters) | 2001 | 2 |
| 10 | Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis Hit paper breakdown → | 2000 | 2401 |
| 11 | 1997 | 0 | |
| 12 | 1992 | 19 | |
| 13 | 1990 | 2 | |
| 14 | Potassium in cardiovascular and renal medicine : arrhythmias, myocardial infarction, and hypertension | 1986 | 7 |
| 15 | Acute renal failure : correlations between morphology and function | 1984 | 15 |
| 16 | The aminoglycosides : microbiology, clinical use, and toxicology | 1982 | 121 |
| 17 | An approach to the interpretation of drug concentrations in the kidney. | 1978 | 4 |
| 18 | Syndrome of perceptive deafness and renal tubular acidosis | 1974 | 9 |
| 19 | Renal medullary cystic disease: a family study | 1974 | 1 |
| 20 | 1968 | 28 |
About Andrew Whelton
Andrew Whelton is a scholar working on Pharmacology, Nephrology, Transplantation, Biochemistry and Pharmacology, having authored 149 papers that have together received 8.3k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (39 papers), Antibiotics Pharmacokinetics and Efficacy (25 papers), Gout, Hyperuricemia, Uric Acid (14 papers), Pharmacological Effects and Toxicity Studies (13 papers), Eicosanoids and Hypertension Pharmacology (12 papers), Pharmacogenetics and Drug Metabolism (12 papers), Metabolism and Genetic Disorders (11 papers) and Blood Pressure and Hypertension Studies (11 papers). The work is most often cited by research in Pharmacology (4.8k citations), Nephrology (1.3k citations), Biochemistry (1.1k citations), Pharmacology (959 citations) and Cardiology and Cardiovascular Medicine (1.9k citations). Andrew Whelton has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Kenneth M. Verburg, Gilbert Geis, J B Lefkowith, William B. White, Gerald A. Faich, Jeffrey D. Kent, Lee S. Simon, Fred E. Silverstein, Glenn M. Eisen and Aimee Burr. Their work appears in journals such as American Journal of Therapeutics, The Journal of Clinical Pharmacology, The American Journal of Medicine, Journal of the American College of Cardiology and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.